As per the SNS Insider Report titled, Organ Preservation Market Size, Share & Segmentation, By Preservation Solution, By Preservation Method, By Organ Type, By End User, By Region, And Global Forecast 2026–2035, “The global Organ Preservation Market size valued at USD 311.36 million in 2025, is anticipated to grow to USD 574.41 million by 2035, registering a CAGR of 6.36% over the 2026–2035 forecast period.”
Key Takeaways:
- The Organ Preservation Market is projected to expand from USD 311.36 million in 2025 to USD 574.41 million by 2035.
- By Preservation Solution, University of Wisconsin (UW) solution dominated the market with a 40.38% share in 2025.
- Custodiol HTK is anticipated to witness the fastest growth, registering a 7.84% CAGR during 2026–2035.
- By Preservation Method, Static Cold Storage (SCS) accounted for the largest 52.15% market share in 2025.
- Normothermic Machine Perfusion (NMP) is expected to grow at the fastest CAGR of 7.56% over the forecast period.
- By Organ Type, Kidney preservation held the leading 48.56% share in 2025.
- Liver preservation is projected to be the fastest-growing segment, advancing at a 7.3% CAGR through 2035.
- By End User, Hospitals captured 72.56% of the market in 2025, while Transplant Centers are expected to register the fastest CAGR of 6.9%. North America held 39.45% market share in 2025, while Asia-Pacific is forecast to grow at a 9.31% CAGR during 2026–2035.
Why Organ Preservation Market is Growing?
The Organ Preservation Market has been showing steady growth owing to the rising prevalence of chronic diseases resulting in end-stage organ failure around the world along with the growing need for organ transplantations. Awareness related to organ donation, governmental support, and improvements in transplant technology infrastructure have resulted in increased numbers of transplants all over the globe. Efforts towards minimizing organ wastage and optimizing transplant efficiency levels through improved preservation methods have helped spur technological innovation in this space.
Machine perfusion techniques are revolutionizing organ storage with extended duration preservation and enhanced evaluation capabilities over conventional practices. Increasing usage of ex-vivo perfusion technologies and investments in transplant technologies along with the developments made in organ preservation technologies are aiding market growth. Moreover, growing healthcare access in developing nations as well as increased transplant activity in the Asia-Pacific region are driving market growth.
Organ Preservation Market Statistics
- As per various international transplant agencies, more than 150,000 organ transplant surgeries are conducted every year around the world, with kidneys comprising the majority.
- The supply of donor organs is not sufficient compared to the number of patients seeking organ transplants.
- Temporary organ preservation through innovative machine perfusion technologies has proven successful, enabling better utilization of organs at risk of rejection.
- Diseases such as liver disease, chronic kidney disease, heart failure, and breathing conditions contribute to a growing demand for organs.
- Donation campaigns and donor registries have made significant strides in developing countries and established markets alike.
- There has been an increased focus by research facilities and healthcare providers in the development of preservation methods for organ success.
- Numerous nations are upgrading their transplant systems and digitized donor matching technologies.
Emerging Trends
One of the key trends influencing the Organ Preservation Market is the increasing use of normothermic machine perfusion, which maintains the metabolic activity of organs during the preservation process. This is an emerging trend because normothermic machine perfusion is being used to assess the quality of organs before transplantation and thus enhance the number of organs suitable for transplantations.
Additionally, one of the latest trends in the organ preservation market involves the development of new generation solutions that aim at minimizing ischemic injuries associated with organ storage and transplantation processes. Biomarker-based approaches to assess organ condition are gaining increasing prominence in this area.
Artificial intelligence and big data analysis are starting to be used to analyze patient and organ condition in order to inform transplantation decision-making. Collaboration between transplant centers, biotechnology companies, and health care institutions has gained momentum lately and is driving further innovations in the sector.
Top 10 Companies
- Bridge to Life Ltd.
- XVIVO Perfusion AB
- Paragonix Technologies
- Organ Recovery Systems
- TransMedics Group, Inc.
- Dr. Franz Köhler Chemie GmbH
- Institut Georges Lopez
- Waters Medical Systems LLC
- Preservation Solutions, Inc.
- Carnamedica